Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023)
Bicycle Therapeutics (BCYC) reported Construction in Progress of $400000.0 for Q2 2023, down 82.61% quarter-over-quarter from $2.3 million in Q4 2022.
Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023) Analysis & Trends
Bicycle Therapeutics has reported Construction in Progress for 2 years, with the latest figure at $400000.0 in Q2 2023.
- For the quarter ending Q2 2023, Construction in Progress changed N/A year-over-year to $400000.0; the trailing twelve-month figure through Jun 2023 stood at $400000.0 (changed N/A YoY), and the FY2022 full-year result was $2.3 million, changed N/A from the prior year.
- Construction in Progress for Q2 2023 stood at $400000.0, down from $2.3 million in the prior quarter.
- The five-year high for Construction in Progress was $2.3 million in Q4 2022, with the low at $400000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 400,000.00 |
| Dec 31, 2022 | 2.30 Mn |